Akt–the Mammalian Target of Rapamycin (mTOR) Pathway Inhibition Increases Cervical Cancer Cell Chemosensitivity to Active Form of Irinotecan (SN-38). IJIHS [Internet]. 2013 Sep. 17 [cited 2026 Jul. 18];1(1):13-21. Available from: https://journal.fk.unpad.ac.id/index.php/ijihs/article/view/103